Synthesis and cytotoxicity of 4-(2-Adamantyl)phenylalkylamines

Letters in Organic Chemistry

Volumn 12, Issue 5, 2015, Pages 319-323

  Papanastasiou, Ioannis ^a   Riganas, Stefanos ^a   Foscolos, George B ^a   Tsotinis, Andrew ^a   Akhtar, Samar A ^b   Khan, Mohsin A ^b   Rahman, Khondaker M ^b   Thurston, David E ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

4 (2 adamantyl)phenylalkylamines; Antiproliferative activity; C 2 substituted adamantane

Indexed keywords

EID: 84931269941     PISSN: 15701786     EISSN: None     Source Type: Journal    
DOI: 10.2174/157017861205150509202419     Document Type: Article

References (13)

1. Zefirova, O. N.; Selyunina, E. V.; Averina, N. V.; Zyk, N. V.; Zefirov, N. S. Synthetic approach to preparation of polycyclic compounds possessing physiological activity: I. Synthesis of 1,4- disubstituted adamantanes with amino acid fragment. Rus. J. Org. Chem., 2002, 38, 1125-1129.
2. Wang, J. J.; Chang, Y. F.; Chern, Y. T.; Chi, C. W. (2003) Study of in vitro and in vivo effects of 1,6-bis[4-(4-amino-3- hydroxyphenoxy)phenyl]diamantane (DPD), a novel cytostatic and differentiation inducing agent, on human colon cancer cells. Br. J. Cancer, 2003, 89, 1995-2003.
3. Smith, C. D.; French, K. J.; Zhuang, Y. Sphingosine kinase inhibitors. US 2006/0287317.
4. Gopalan, B.; Ponpandian, T.; Kachhadia, V.; Bharathimohan A.; Vignesh, R.; Sivasudar, V.; Narayanan, S.; Mandar, B.; Praveen, R.; Saranya, N.; Rajagopal, S. Discovery of adamantane based highly potent HDAC inhibitors. Bioorg. Med. Chem. Lett., 2013, 23, 2532-2537.
5. Riganas, S.; Papanastasiou, I.; Foscolos, G. B.; Tsotinis, A.; Bourguignon, J. J.; Serin, G.; Mirjolet, J. F.; Dimas, K.; Kourafalos ,V. N.; Eleutheriades, A.; Moutsos, V. I.; Khan, H.; Georgakopoulou, S.; Zaniou, A.; Prassa, M.; Theodoropoulou, M.; Pondiki, S.; Vamvakides, A. Synthesis, σ1, σ2-receptors binding affinity and antiproliferative action of new C1-substituted adamantanes. Bioorg. Med. Chem., 2012, 20, 3323-3331.
6. Riganas, S.; Papanastasiou, I.; Foscolos, G. B.; Tsotini,s A.; Dimas, K.; Kourafalos, V. N.; Eleutheriades, A.; Moutsos, V.I.; Khan, H.; Prassa, M.; Georgakopoulou, S.; Zaniou, A.; Theodoropoulou, M.; Mantelas, A.; Pondiki, S.; Vamvakides, A. New adamantane derivatives with sigma affinity and antiproliferative activity. Med. Chem., 2012, 8, 569-586.
7. Riganas S, Papanastasiou, I.; Foscolos, G. B.; Tsotinis, A.; Serin, G.; Mirjolet, J. F.; Dimas, K.; Kourafalos, V. N.; Eleutheriades, A.; Moutsos ,V. I; Khan, H.; Georgakopoulou, S.; Zaniou, A.; Prassa, M.; Theodoropoulou, M.; Mantelas, A.; Pondiki, S.; Vamvakides, A. New sigma-receptors binding adamantane phenylalkylamines with anti-cancer activity associated with putative antagonism of neuropathic pain. J. Med. Chem,. 2012, 55,10241-61.
8. Borch, R. F.; Hassid, A. I. New method for the methylation of amines. J. Org. Chem ., 1972, 37, 1673-1674.
9. Abdel-Magid, A. F.; Carson, K. G.; Harris, B. D.; Manganoff, C. A.; Shah, R. D. Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures (1). J. Org. Chem., 1991, 61, 3849-3862.
10. Renaud, J.; Bischoff, S. F.; Buhl, T.; Floersheim, P.; Fournier, B.; Geiser.; Halleux ,C.; Kallen, J.; Keller, H.; Ramage, P. Selective estrogen receptors with conformationally restricted side chain, synthesis and structure-activity relationship of eralpha- selective tetrahydroisoquinoline ligands. J. Med. Chem., 2005, 48, 364-379.
11. Singh, C. B.; Kavala, V.; Samal, A. K.; Patel, B. K. Aqueous mediated N-alkylation of amines. Eur J Org Chem., 2007, 1369-1377.
12. Lin, M. H.; Silver, J. E.; Le Noble, W. J. Search for nucleophilicity effect on the face selectivity of addition to a sterically unbiased ketone. J. Org. Chem., 1988, 53, 5155-5158.
13. Erokhina, E. V.; Shokova, E.A.; Luzikov, Y. N.; Kovalev, V. V. Dichlorophosphorylation of adamantanols and 1-adamantylcarbinols in trifluoroacetic acid. Synthesis, 1995, 7, 851-854.